Aplicación de la evidencia en la práctica clínica del tratamiento de las úlceras de pie diabético mediante apósitos de octosulfato de sacarosa

  1. José Luis Lázaro Martínez 1
  2. Yolanda García Álvarez 1
  3. Esther García Morales 1
  1. 1 Universidad Complutense de Madrid
    info

    Universidad Complutense de Madrid

    Madrid, España

    ROR 02p0gd045

Revista:
Revista ROL de enfermería

ISSN: 0210-5020

Año de publicación: 2019

Volumen: 42

Número: 9

Páginas: 8-15

Tipo: Artículo

Otras publicaciones en: Revista ROL de enfermería

Referencias bibliográficas

  • Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376(24):2367-75.
  • Bus SA, van Netten JJ, Lavery LA, Monteiro- Soares M, Rasmussen A, Jubiz Y et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1:16-24.
  • Edmonds M, Lazaro-Martinez JL, Alfayate- Garcia JM, Martini J, Petit JM, Rayman G et al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018;6(3):186-96.
  • Game FL, Attinger C, Hartemann A, Hinchliffe RJ, Londahl M, Price PE et al. IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1:75-83.
  • Gerry Rayman PV, Ketan Dhatariya, Vicki Driver, Agnes Hartemann, Magnus Londahl, Alberto Piaggesi, Jan Apelqvist, Chris Attinger, Fran Game. IWGDF Guideline on interventions to enhance healing of foot ulcers in persons with diabetes. IWGDF Practical guidelines on the prevention and management of diabetic foot disease 2019. https://iwgdfguidelines.org/wpcontent/ uploads/2019/05/06-IWGDF-recommendations- wound-healing-2019.pdf.
  • Jupiter DC, Thorud JC, Buckley CJ, Shibuya N. The impact of foot ulceration and amputation on mortality in diabetic patients. I: From ulceration to death, a systematic review. Int Wound J. 2016;13(5):892-903.
  • Lazaro JL, Izzo V, Meaume S, Davies AH, Lobmann R, Uccioli L. Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence. J Wound Care. 2016;25(5):277-87.
  • Lazaro-Martinez JL, Edmonds M, Rayman G, Apelqvist J, Van Acker K, Hartemann A et al. Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer. J Wound Care. 2019;28(6):358-67.
  • Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol. 2000;136(12):1531-5.
  • Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26(2):491-4.
  • Munter KC, Meaume S, Augustin M, Senet P, Kerihuel JC. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings. J Wound Care. 2017;26(Sup2):S4-S15.
  • Narres M, Kvitkina T, Claessen H, Droste S, Schuster B, Morbach S et al. Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review. PLoS One. 2017;12(8):e0182081.
  • Nice Guidance 2019. UrgoStart for treating diabetic foot ulcers and leg ulcers. Nice medical technologies guidance. Published date: January 2019. www.nice.org.uk/guidance/mtg42.
  • Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50(1):18-25.
  • Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med. 2008;25(6):700-7.
  • Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826-34.
  • Richard JL, Martini J, Bonello Faraill MM, Bemba JM, Lepeut M, Truchetet F et al. Management of diabetic foot ulcers with a TLC-NOSF wound dressing. J Wound Care. 2012;21(3):142-7.
  • Richmond NA, Vivas AC, Kirsner RS. Topical and biologic therapies for diabetic foot ulcers. Med Clin North Am. 2013;97(5):883-98.
  • Sigal ML, Addala A, Maillard H, Chahim M, Sala F, Blaise S et al. Evaluation of TLC-NOSF dressing with poly-absorbent fibres in exuding leg ulcers: two multicentric, single-arm, prospective, open-label clinical trials. J Wound Care. 2019;28(3):164-75.